ATE220538T1 - Ophthalmologische zusammensetzung, die ein ionenempfindliches polymer und ein anorganisches salz in einem verhältnis enthält, das eine niedrige viskosität ergibt - Google Patents

Ophthalmologische zusammensetzung, die ein ionenempfindliches polymer und ein anorganisches salz in einem verhältnis enthält, das eine niedrige viskosität ergibt

Info

Publication number
ATE220538T1
ATE220538T1 AT95914363T AT95914363T ATE220538T1 AT E220538 T1 ATE220538 T1 AT E220538T1 AT 95914363 T AT95914363 T AT 95914363T AT 95914363 T AT95914363 T AT 95914363T AT E220538 T1 ATE220538 T1 AT E220538T1
Authority
AT
Austria
Prior art keywords
pct
ion sensitive
polymer
composition containing
low viscosity
Prior art date
Application number
AT95914363T
Other languages
English (en)
Inventor
Kari Lehmussaari
Eija Vartiainen
Timo Reunamaeki
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE220538T1 publication Critical patent/ATE220538T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95914363T 1994-03-31 1995-03-29 Ophthalmologische zusammensetzung, die ein ionenempfindliches polymer und ein anorganisches salz in einem verhältnis enthält, das eine niedrige viskosität ergibt ATE220538T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401109A SE9401109D0 (sv) 1994-03-31 1994-03-31 Opthalmic composition II
PCT/FI1995/000167 WO1995026712A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity

Publications (1)

Publication Number Publication Date
ATE220538T1 true ATE220538T1 (de) 2002-08-15

Family

ID=20393512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95914363T ATE220538T1 (de) 1994-03-31 1995-03-29 Ophthalmologische zusammensetzung, die ein ionenempfindliches polymer und ein anorganisches salz in einem verhältnis enthält, das eine niedrige viskosität ergibt

Country Status (25)

Country Link
US (1) US5795913A (de)
EP (1) EP0755246B1 (de)
JP (1) JPH10503471A (de)
KR (1) KR970702025A (de)
CN (1) CN1114399C (de)
AT (1) ATE220538T1 (de)
AU (1) AU694498B2 (de)
BG (1) BG63144B1 (de)
BR (1) BR9507439A (de)
CA (1) CA2186591A1 (de)
CZ (1) CZ286496A3 (de)
DE (2) DE69527422T2 (de)
DK (1) DK0755246T3 (de)
EE (1) EE03662B1 (de)
ES (1) ES2179871T3 (de)
HU (1) HU223070B1 (de)
MX (1) MX9603919A (de)
NO (1) NO314435B1 (de)
PL (1) PL316585A1 (de)
PT (1) PT755246E (de)
RO (1) RO115410B1 (de)
RU (1) RU2157194C2 (de)
SE (1) SE9401109D0 (de)
SK (1) SK281473B6 (de)
WO (1) WO1995026712A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY116782A (en) 1997-12-22 2004-03-31 Otsuka Pharma Co Ltd Water-soluble eye drop
WO2000064528A1 (en) 1999-04-28 2000-11-02 Situs Corporation Drug delivery system
AT407482B (de) * 1999-05-10 2001-03-26 Armin Dr Ettl Kalziumantagonistische augentropfen zur prophylaktischen behandlung der cataract
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
WO2003072081A1 (en) * 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic formulation with gum system
US7030149B2 (en) 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
ATE528003T1 (de) 2002-07-31 2011-10-15 Senju Pharma Co Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
IL212725A (en) 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017197051A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Amine-linked c3-glutarimide degronimers for target protein degradation
AU2017275492A1 (en) * 2016-06-01 2018-12-20 Harold Richard Hellstrom Treatment of dry eye disease with parasympathetic and anti-sympathetic agents
EP3939591A1 (de) 2016-06-27 2022-01-19 Achillion Pharmaceuticals, Inc. Chinazolin- und indolverbindungen zur behandlung von medizinischen leiden
WO2018033792A2 (en) 2016-08-19 2018-02-22 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
AU2018227849B2 (en) 2017-03-01 2022-04-28 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
CN111902141A (zh) 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
HRP20220762T1 (hr) * 2018-04-24 2022-09-16 Allergan, Inc. Upotreba pilokarpin-hidroklorida u liječenju prezbiopije
JP7538113B2 (ja) 2018-08-20 2024-08-21 アキリオン ファーマシューティカルズ,インコーポレーテッド 補体d因子の医学的障害の治療のための医薬化合物
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
KR20210152515A (ko) 2019-04-12 2021-12-15 씨4 테라퓨틱스, 인코포레이티드 이카로스 및 아이올로스의 트리시클릭 분해제
CN115362162A (zh) 2020-02-20 2022-11-18 艾其林医药公司 用于治疗补体因子d介导的障碍的杂芳基化合物
MX2022010952A (es) 2020-03-05 2022-10-07 C4 Therapeutics Inc Compuestos para la degradacion dirigida de brd9.
JP7787164B2 (ja) 2020-09-23 2025-12-16 アキリオン ファーマシューティカルズ, インコーポレーテッド 補体媒介性障害の治療のための医薬化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
GB2169508B (en) * 1985-01-11 1989-02-01 Smith & Nephew Ass Ophthalmic compositions and use
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
RU2007152C1 (ru) * 1992-10-01 1994-02-15 Курский Государственный Медицинский Институт Офтальмологическое средство и способ его получения

Also Published As

Publication number Publication date
HU223070B1 (hu) 2004-03-01
NO964071D0 (no) 1996-09-27
JPH10503471A (ja) 1998-03-31
CN1144476A (zh) 1997-03-05
CZ286496A3 (en) 1997-03-12
SK281473B6 (sk) 2001-04-09
PL316585A1 (en) 1997-01-20
CA2186591A1 (en) 1995-10-12
EP0755246A1 (de) 1997-01-29
KR970702025A (ko) 1997-05-13
BR9507439A (pt) 1997-09-16
MX9603919A (es) 1997-04-30
WO1995026712A1 (en) 1995-10-12
RU2157194C2 (ru) 2000-10-10
SE9401109D0 (sv) 1994-03-31
EE03662B1 (et) 2002-04-15
HU9602692D0 (en) 1996-11-28
DE69527422D1 (de) 2002-08-22
SK123896A3 (en) 1997-06-04
US5795913A (en) 1998-08-18
DE755246T1 (de) 1997-09-04
DE69527422T2 (de) 2003-03-20
RO115410B1 (ro) 2000-02-28
NO964071L (no) 1996-11-22
ES2179871T3 (es) 2003-02-01
HUT75664A (en) 1997-05-28
PT755246E (pt) 2002-11-29
AU694498B2 (en) 1998-07-23
DK0755246T3 (da) 2002-11-04
EE9600157A (et) 1997-06-16
EP0755246B1 (de) 2002-07-17
AU2139095A (en) 1995-10-23
BG100914A (en) 1997-07-31
NO314435B1 (no) 2003-03-24
CN1114399C (zh) 2003-07-16
BG63144B1 (bg) 2001-05-31

Similar Documents

Publication Publication Date Title
ATE220538T1 (de) Ophthalmologische zusammensetzung, die ein ionenempfindliches polymer und ein anorganisches salz in einem verhältnis enthält, das eine niedrige viskosität ergibt
EE9600120A (et) Vähendatud viskoossusega oftalmoloogiline kompositsioon
US5945121A (en) Liposome eye drops
DE68929031T2 (de) Antimikrobielle wässerige Lösungen für die Kontaktlinsenpflege
US4440662A (en) Cleaning composition for contact lenses
DE2918799A1 (de) Ophthalmische loesung
KR940006575A (ko) 증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
DE60119337T2 (de) Aseptische mittel
DE3625867C2 (de) Verwendung von Tetrachlordecaoxid in der Ophthalmologie
DE3700379A1 (de) Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
DE69914937T2 (de) Betablocker und carbopol enthaltende ophtalmische zusammensetzung
DE3415663A1 (de) Eine neue ophthalmologische verabreichungsform

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0755246

Country of ref document: EP

REN Ceased due to non-payment of the annual fee